JAK1 mutations have mainly been observed in T-ALL and high-risk B-ALL while JAK2 mutations have been identified in Down syndrome [52] and high-risk B-ALL [34,54]. This evidence concerns the gene JAK2 and acute lymphoblastic leukemia.